Business Context and Reporting Period
Company: Bruker Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: May 12, 2009
Event: Regulation FD Disclosure regarding participation in the Bank of America and Merrill Lynch 2009 Healthcare Conference in New York, New York.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the presentation of slides (Exhibit 99.1) at an investor conference.
Material Changes
No material financial changes or operational updates are detailed within the text of this filing. The document references attached presentation slides for further information but does not summarize their content.
Guidance, Outlook, and Risks
Management Commentary: The Company will present slides at the aforementioned conference. These slides are available on the Company's investor relations website.
Legal Status: The information in this report and its exhibits is furnished and shall not be deemed "filed" under Section 18 of the Exchange Act, nor is it subject to the liabilities of that Section. It is not incorporated by reference into other filings unless specifically identified.
Investor Verification Checklist
- Verify the content of the presentation slides attached as Exhibit 99.1, as the filing text contains no financial data.
- Review the Company's investor relations website (http://www.bruker.com) for the posted presentation materials.
- Confirm that no other concurrent filings contain the financial details referenced in the conference presentation.